Table 3.
Group4, % | |||||||
---|---|---|---|---|---|---|---|
Tissue | Fatty acid | CON | L-ALA | H-ALA | EPA | n-3 | n-6 |
blood | EPA | ND2,a | 4.05 ± 0.31b | 7.22 ± 0.28c | 10.1 ± 0.75e | 8.90 ± 0.37d | NDa |
DPA | NDa | 1.54 ± 0.04c | 2.14 ± 0.07d | 2.57 ± 0.18e | 1.20 ± 0.04b | NDa | |
DHA | 1.69 ± 0.11b | 5.50 ± 0.21d | 4.49 ± 0.29c | 6.19 ± 0.24d | 9.90 ± 0.52e | 0.78 ± 0.09a | |
Total3 | 1.69 ± 0.11a | 11.1 ± 0.46b | 13.9 ± 0.54c | 19.8 ± 0.53d | 20.0 ± 0.83d | 0.78 ± 0.09a | |
liver | EPA | NDa | 4.90 ± 0.39b | 9.68 ± 0.46c | 8.29 ± 0.83c | 5.77 ± 0.52b | NDa |
DPA | 0.11 ± 0.00a | 1.58 ± 0.11b | 2.18 ± 0.14c | 3.90 ± 0.45d | 1.84 ± 0.14b,c | 0.12 ± 0.02a | |
DHA | 1.70 ± 0.17a | 10.9 ± 1.24b | 9.41 ± 0.59b | 14.0 ± 0.57c | 22.0 ± 0.77d | 1.98 ± 0.21a | |
Total | 1.72 ± 0.18a | 18.8 ± 1.04b | 21.3 ± 0.80c | 26.2 ± 1.19d | 29.6 ± 0.80e | 2.07 ± 0.22a | |
epididymal fat pad | EPA | NDa | 0.11 ± 0.01a | 0.20 ± 0.01a | 2.31 ± 0.15c | 1.49 ± 0.18b | NDa |
DPA | NDa | 0.17 ± 0.01a | 0.28 ± 0.01b | 0.86 ± 0.09c | 0.93 ± 0.07c | NDa | |
DHA | NDa | 0.18 ± 0.02a | 0.16 ± 0.03a | 0.64 ± 0.07b | 2.76 ± 0.23c | NDa | |
Total | NDa | 0.46 ± 0.03a,b | 0.64 ± 0.03b | 3.81 ± 0.28c | 5.17 ± 0.44d | NDa | |
prostate | EPA | NDa | 2.04 ± 0.26b | 3.82 ± 0.41c | 4.33 ± 0.96c | 3.43 ± 0.54c | NDa |
DPA | NDa | 2.30 ± 0.28b | 4.12 ± 0.30c | 4.14 ± 0.73c | 1.75 ± 0.13b | NDa | |
DHA | 2.18 ± 0.10a | 4.80 ± 0.54b | 5.14 ± 0.13b | 7.58 ± 0.63c | 9.93 ± 0.72d | 1.01 ± 0.13a | |
Total | 2.18 ± 0.10a | 9.15 ± 0.87b | 13.1 ± 0.28c | 16.1 ± 2.18d | 15.1 ± 0.95c,d | 1.01 ± 0.13a |
1Values are means ± SEMs (n = 6). Labeled means without a common letter differ, p < 0.05
2ND, not detected
3Total, the sum of EPA, DPA and DHA
4Data expressed as percentage of total fatty acids. L-ALA, low-ALA; H-ALA, high-ALA; CON, control